138 related articles for article (PubMed ID: 29730354)
21. Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.
Jalagadugula G; Mao G; Kaur G; Dhanasekaran DN; Rao AK
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):921-7. PubMed ID: 21252065
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of Runx1 at Ser249, Ser266, and Ser276 is dispensable for bone marrow hematopoiesis and thymocyte differentiation.
Tachibana M; Tezuka C; Muroi S; Nishimoto S; Katsumoto T; Nakajima A; Kitabayashi I; Taniuchi I
Biochem Biophys Res Commun; 2008 Apr; 368(3):536-42. PubMed ID: 18261462
[TBL] [Abstract][Full Text] [Related]
23. Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model.
Borst S; Nations CC; Klein JG; Pavani G; Maguire JA; Camire RM; Drazer MW; Godley LA; French DL; Poncz M; Gadue P
Stem Cell Reports; 2021 Jun; 16(6):1458-1467. PubMed ID: 34019812
[TBL] [Abstract][Full Text] [Related]
24. Non-receptor tyrosine kinases c-Abl and Arg regulate the activity of C/EBPbeta.
Li X; Liu X; Wang G; Zhu X; Qu X; Li X; Yang Y; Peng L; Li C; Li P; Huang W; Ma Q; Cao C
J Mol Biol; 2009 Aug; 391(4):729-43. PubMed ID: 19563810
[TBL] [Abstract][Full Text] [Related]
25. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
28. Overexpression or knock-down of runt-related transcription factor 1 affects BCR-ABL-induced proliferation and migration in vitro and leukemogenesis in vivo in mice.
Yang LJ; Yu WD; DU JB; Chao S; Chen MX; Zhao HH; Guo JZ
Chin Med J (Engl); 2009 Feb; 122(3):331-7. PubMed ID: 19236814
[TBL] [Abstract][Full Text] [Related]
29. c-Abl-mediated tyrosine phosphorylation of JunB is required for Adriamycin-induced expression of p21.
Yamaguchi N; Yuki R; Kubota S; Aoyama K; Kuga T; Hashimoto Y; Tomonaga T; Yamaguchi N
Biochem J; 2015 Oct; 471(1):67-77. PubMed ID: 26217035
[TBL] [Abstract][Full Text] [Related]
30. PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.
Wee HJ; Voon DC; Bae SC; Ito Y
Blood; 2008 Nov; 112(9):3777-87. PubMed ID: 18695000
[TBL] [Abstract][Full Text] [Related]
31. Abl-1-bridged tyrosine phosphorylation of VASP by Abelson kinase impairs association of VASP to focal adhesions and regulates leukaemic cell adhesion.
Maruoka M; Sato M; Yuan Y; Ichiba M; Fujii R; Ogawa T; Ishida-Kitagawa N; Takeya T; Watanabe N
Biochem J; 2012 Feb; 441(3):889-99. PubMed ID: 22014333
[TBL] [Abstract][Full Text] [Related]
32. Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer.
Voora D; Rao AK; Jalagadugula GS; Myers R; Harris E; Ortel TL; Ginsburg GS
EBioMedicine; 2016 Sep; 11():157-164. PubMed ID: 27566955
[TBL] [Abstract][Full Text] [Related]
33. Loss of RUNX1/AML1 arginine-methylation impairs peripheral T cell homeostasis.
Mizutani S; Yoshida T; Zhao X; Nimer SD; Taniwaki M; Okuda T
Br J Haematol; 2015 Sep; 170(6):859-73. PubMed ID: 26010396
[TBL] [Abstract][Full Text] [Related]
34. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis.
Ichikawa M; Asai T; Chiba S; Kurokawa M; Ogawa S
Cell Cycle; 2004 Jun; 3(6):722-4. PubMed ID: 15213471
[TBL] [Abstract][Full Text] [Related]
35. Structural basis of Ets1 activation by Runx1.
Shrivastava T; Mino K; Babayeva ND; Baranovskaya OI; Rizzino A; Tahirov TH
Leukemia; 2014 Oct; 28(10):2040-8. PubMed ID: 24646888
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
[TBL] [Abstract][Full Text] [Related]
37. c-Abl-mediated tyrosine phosphorylation of the T-bet DNA-binding domain regulates CD4+ T-cell differentiation and allergic lung inflammation.
Chen A; Lee SM; Gao B; Shannon S; Zhu Z; Fang D
Mol Cell Biol; 2011 Aug; 31(16):3445-56. PubMed ID: 21690296
[TBL] [Abstract][Full Text] [Related]
38. RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects.
Lee K; Ahn HS; Estevez B; Poncz M
Blood; 2023 Jan; 141(3):260-270. PubMed ID: 36219879
[TBL] [Abstract][Full Text] [Related]
39. Histone arginine methylation keeps RUNX1 target genes in an intermediate state.
Herglotz J; Kuvardina ON; Kolodziej S; Kumar A; Hussong H; Grez M; Lausen J
Oncogene; 2013 May; 32(20):2565-75. PubMed ID: 22777353
[TBL] [Abstract][Full Text] [Related]
40. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals.
Takizawa H; Eto K; Yoshikawa A; Nakauchi H; Takatsu K; Takaki S
Exp Hematol; 2008 Jul; 36(7):897-906. PubMed ID: 18456388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
